Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baiyunshan Tangyin Dongtai Pharmaceutical is a Chinese pharmaceutical company and a subsidiary of the Guangzhou Baiyunshan Pharmaceutical Group. Located in Tangyin County, Henan Province, the company specializes in the research, development, and large-scale manufacturing of both Traditional Chinese Medicines (TCM) and chemical drug formulations. Its product portfolio primarily focuses on pediatric health, gastrointestinal treatments, and general wellness products, including well-known brands such as Xiaoer Qixingcha. The company operates modern GMP-certified production facilities and serves as a key manufacturing hub for the broader Baiyunshan brand in Central China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baiyunshan Tangyin Dongtai Pharmaceutical.